ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
4DMEDICAL LTD
3.880
+0.210
5.72%
成交量:
287.70萬
成交額:
1,079.37萬
市值:
23.19億
市盈率:
-9.40
高:
3.890
開:
3.690
低:
3.640
收:
3.670
52周最高:
7.550
52周最低:
0.472
股本:
5.98億
流通股本:
3.78億
量比:
0.83
換手率:
0.76%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.413
每股收益(LYR):
-0.140
淨資產收益率:
-1099.31%
總資產收益率:
-26.14%
市淨率:
-81.63
市盈率(LYR):
-27.71
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
4DMedical獲澳大利亞TGA批准CTVQ技術
投资观察
·
06/26
異動解讀 | 4DMedical推出臨床證據計劃,股價盤中大漲5.38%
异动解读
·
06/02
4DMedical推出明確臨床證據計劃,旨在加速Ct:Vq™進入急性肺栓塞市場
美股速递
·
06/02
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/4DX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.88,"timestamp":1787638320000,"preClose":3.67,"halted":0,"volume":2877029,"delay":0,"changeRate":0.057220708446866476,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":597559121,"eps":-0.412693,"marketStatus":"未開盤","change":0.21,"latestTime":"08-25 16:12:00 AEST","open":3.69,"high":3.89,"low":3.64,"amount":10793728,"amplitude":0.06812,"askPrice":3.89,"askSize":7335,"bidPrice":3.85,"bidSize":1282,"shortable":3,"etf":0,"ttmEps":-0.412693,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.67,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.8275735047099285,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":3.67,"auctionPrice":3.88,"auctionVolume":71417,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638203502}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-26.14%","roe":"-1099.31%","lyrEps":-0.14,"volumeRatio":0.8275735047099285,"shares":597559121,"dividePrice":0,"high":3.89,"amplitude":0.06812,"preClose":3.67,"low":3.64,"week52Low":0.472,"pbRate":"-81.63","psRate":"399.03","week52High":7.55,"institutionHeld":0,"latestPrice":3.88,"committee":-0.702449,"eps":-0.412693,"divideRate":0,"volume":2877029,"delay":0,"ttmEps":-0.412693,"open":3.69,"prevYearClose":3.93,"prevWeekClose":3.83,"prevMonthClose":3.63,"prevQuarterClose":4.53,"fiveDayClose":3.76,"twentyDayClose":3.25,"sixtyDayClose":4.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127775213","title":"4DMedical獲澳大利亞TGA批准CTVQ技術","url":"https://stock-news.laohu8.com/highlight/detail?id=1127775213","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127775213?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 09:37","pubTimestamp":1782437859,"startTime":"0","endTime":"0","summary":"4DMedical Ltd宣布,其CTVQ技术已获得澳大利亚治疗商品管理局的批准。这一监管进展为该公司在澳大利亚市场的业务拓展奠定了基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149159643","title":"異動解讀 | 4DMedical推出臨床證據計劃,股價盤中大漲5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149159643","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149159643?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 08:03","pubTimestamp":1780358589,"startTime":"0","endTime":"0","summary":"4DMedical有限公司(股票代码:4DX.AU)今日盘中大涨5.38%,引起了市场的关注。消息面上,公司宣布启动一项明确的临床证据计划,该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞(PE)市场铺平道路,这被视为一项积极的业务进展,增强了投资者对公司未来增长潜力的信心。该临床证据计划的核心目标是通过生成坚实的临床数据,来支持这项创新技术在关键医疗领域的应用与采纳,市场预期此举将有助于公司拓展新的市场机会。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146205447","title":"4DMedical推出明確臨床證據計劃,旨在加速Ct:Vq™進入急性肺栓塞市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1146205447","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146205447?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 06:32","pubTimestamp":1780353139,"startTime":"0","endTime":"0","summary":"4DMedical有限公司宣布启动一项明确的临床证据计划,该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞(PE)市场铺平道路。该计划的核心目标是通过生成坚实的临床数据,来支持这项创新技术在关键医疗领域的应用与采纳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/4DX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}